OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Combination Ad26.RSV.preF/preF protein vaccine induces superior protective immunity compared with individual vaccine components in preclinical models
Eiríkur Saeland, Leslie van der Fits, Renske Bolder, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 8
Eiríkur Saeland, Leslie van der Fits, Renske Bolder, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 8
Showing 8 citing articles:
Progress on Respiratory Syncytial Virus Vaccine Development and Evaluation Methods
Lie Deng, H. Cao, Guichang Li, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 304-304
Open Access
Lie Deng, H. Cao, Guichang Li, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 304-304
Open Access
Safety, Immunogenicity, and Regimen Selection of Ad26.RSV.preF–Based Vaccine Combinations: A Randomized, Double-blind, Placebo-Controlled, Phase 1/2a Study
Christy Comeaux, Stephan Bart, Arangassery Rosemary Bastian, et al.
The Journal of Infectious Diseases (2023) Vol. 229, Iss. 1, pp. 19-29
Open Access | Times Cited: 12
Christy Comeaux, Stephan Bart, Arangassery Rosemary Bastian, et al.
The Journal of Infectious Diseases (2023) Vol. 229, Iss. 1, pp. 19-29
Open Access | Times Cited: 12
A Randomized, Double‐Blind, Placebo‐Controlled, Phase 1 Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Single Vaccination of Ad26.RSV.preF‐Based Regimen in Japanese Adults Aged 60 Years and Older
Takashi Eto, Yusuke Okubo, Atsushi Momose, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 6
Open Access | Times Cited: 3
Takashi Eto, Yusuke Okubo, Atsushi Momose, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 6
Open Access | Times Cited: 3
RSV A2-Based Prefusion F Vaccine Candidates Induce RSV A and RSV B Cross Binding and Neutralizing Antibodies and Provide Protection against RSV A and RSV B Challenge in Preclinical Models
Freek Cox, Eiríkur Saeland, Anne Thoma, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 672-672
Open Access | Times Cited: 9
Freek Cox, Eiríkur Saeland, Anne Thoma, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 672-672
Open Access | Times Cited: 9
Immunogenicity and safety of Ad26.RSV.preF/RSV preF protein vaccine at predicted intermediate- and end-of-shelf-life as an evaluation of potency throughout shelf life
Tessa Hosman, Roy van Heesbeen, Arangassery Rosemary Bastian, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 2
Tessa Hosman, Roy van Heesbeen, Arangassery Rosemary Bastian, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 2
A foldon-free prefusion F trimer vaccine for respiratory syncytial virus to reduce off-target immune responses
Mark J. G. Bakkers, Freek Cox, Annemart Koornneef, et al.
Nature Microbiology (2024)
Open Access | Times Cited: 1
Mark J. G. Bakkers, Freek Cox, Annemart Koornneef, et al.
Nature Microbiology (2024)
Open Access | Times Cited: 1
Mucosal delivery of a prefusogenic-F, glycoprotein, and matrix proteins-based virus-like particle respiratory syncytial virus vaccine induces protective immunity as evidenced by challenge studies in mice
Ahmedali S. Mandviwala, Anke Huckriede, Vidya A. Arankalle, et al.
Virology (2024) Vol. 598, pp. 110194-110194
Open Access
Ahmedali S. Mandviwala, Anke Huckriede, Vidya A. Arankalle, et al.
Virology (2024) Vol. 598, pp. 110194-110194
Open Access
Induction of neutralizing antibody responses by AAV5-based vaccine for respiratory syncytial virus in mice
Guangxu Ma, Zeping Xu, Chinyu Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Guangxu Ma, Zeping Xu, Chinyu Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
A self-amplifying RNA RSV prefusion-F vaccine elicits potent immunity in pre-exposed and naïve non-human primates
Aneesh Vijayan, Ronald Vogels, Rachel Groppo, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access
Aneesh Vijayan, Ronald Vogels, Rachel Groppo, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access
